Intracoronary irradiation for the prevention of restenosis.
Restenosis after coronary angioplasty is a major limitation of an otherwise highly effective and safe procedure for the treatment of atherosclerotic coronary artery disease. Although the advent of coronary stenting has reduced restenosis rates for selected patients, an overall restenosis rate of 20% to 25% remains. Despite numerous trials, no effective pharmacologic therapy has been found. Intracoronary irradiation is a new technique proposed to prevent restenosis after angioplasty. In animal models of restenosis after balloon injury, there is marked reduction of neointimal proliferation when the injured vessel is irradiated, using a variety of radiation sources and delivery systems. Early human trials have underscored the importance of careful source calibration and dosimetry. A small, randomized, double-blind, placebo-controlled study of intracoronary irradiation to prevent recurrent restenosis recently reported striking reductions in angiographic restenosis as well as clinical event rates. A number of important issues remain unresolved, such as defining which component of the arterial wall serves as the target tissue for radiation, the minimal effective dose, the maximum tolerable dose, and user-friendly radiation delivery systems. Further studies are needed to define the safety, efficacy and the ultimate usefulness of intracoronary irradiation as an adjunct to current procedures in interventional cardiology.
Weinberger
J
J
Interventional Cardiology Center, Columbia-Presbyterian Medical Center, New York, NY 10032, USA.
Simon
A D
AD
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D000818:Animals; D001918:Brachytherapy / Q000295:instrumentation*; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000473:pathology / Q000528:radiation effects*; D011879:Radiotherapy Dosage; D012008:Recurrence; D016896:Treatment Outcome